Strategic Financial Services’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,334
| Closed | -$266K | – | 155 |
|
|
2025
Q4 | $266K | Hold |
1,334
| – | – | 0.01% | 122 |
|
|
2025
Q3 | $221K | Buy |
+1,334
| New | +$218K | 0.01% | 131 |
|
|
2025
Q2 | – | Sell |
-1,288
| Closed | -$203K | – | 139 |
|
|
2025
Q1 | $203K | Buy |
+1,288
| New | +$209K | 0.01% | 132 |
|
|
2024
Q4 | – | Sell |
-1,238
| Closed | -$220K | – | 137 |
|
|
2024
Q3 | $220K | Hold |
1,238
| – | – | 0.01% | 135 |
|
|
2024
Q2 | $209K | Buy |
+1,238
| New | +$202K | 0.01% | 129 |
|
|
2020
Q1 | – | Sell |
-2,575
| Closed | -$359K | – | 122 |
|
|
2019
Q4 | $359K | Sell |
2,575
-9,327
| -78% | -$1.23M | 0.04% | 113 |
|
|
2019
Q3 | $1.4M | Sell |
11,902
-1,052
| -8% | -$131K | 0.18% | 88 |
|
|
2019
Q2 | $1.67M | Sell |
12,954
-2,627
| -17% | -$324K | 0.22% | 85 |
|
|
2019
Q1 | $2M | Sell |
15,581
-10,882
| -41% | -$1.37M | 0.28% | 88 |
|
|
2018
Q4 | $2.93M | Sell |
26,463
-303
| -1% | -$36.6K | 0.46% | 59 |
|
|
2018
Q3 | $3.64M | Sell |
26,766
-155
| -0.6% | -$20.2K | 0.54% | 51 |
|
|
2018
Q2 | $3.23M | Sell |
26,921
-105
| -0.4% | -$12.4K | 0.5% | 58 |
|
|
2018
Q1 | $3.25M | Sell |
27,026
-206
| -0.8% | -$25.9K | 0.53% | 58 |
|
|
2017
Q4 | $3.39M | Buy |
27,232
+60
| +0.2% | +$7.66K | 0.54% | 63 |
|
|
2017
Q3 | $3.65M | Buy |
27,172
+200
| +0.7% | +$26K | 0.6% | 54 |
|
|
2017
Q2 | $3.39M | Sell |
26,972
-40
| -0.1% | -$4.82K | 0.59% | 59 |
|
|
2017
Q1 | $3.22M | Buy |
27,012
+80
| +0.3% | +$9.36K | 0.58% | 62 |
|
|
2016
Q4 | $2.9M | Sell |
26,932
-245
| -0.9% | -$26.6K | 0.56% | 66 |
|
|
2016
Q3 | $3.13M | Buy |
27,177
+115
| +0.4% | +$13.1K | 0.62% | 59 |
|
|
2016
Q2 | $3.12M | Sell |
27,062
-393
| -1% | -$41.9K | 0.63% | 59 |
|
|
2016
Q1 | $2.85M | Buy |
27,455
+5,558
| +25% | +$580K | 0.66% | 66 |
|
|
2015
Q4 | $2.78M | Buy |
21,897
+317
| +1% | +$38.8K | 0.73% | 62 |
|
|
2015
Q3 | $2.47M | Buy |
21,580
+100
| +0.5% | +$13.2K | 0.68% | 69 |
|
|
2015
Q2 | $2.9M | Sell |
21,480
-415
| -2% | -$55.2K | 0.81% | 55 |
|
|
2015
Q1 | $2.84M | Sell |
21,895
-90
| -0.4% | -$11.3K | 0.73% | 67 |
|
|
2014
Q4 | $2.54M | Sell |
21,985
-315
| -1% | -$35.5K | 0.69% | 76 |
|
|
2014
Q3 | $2.36M | Sell |
22,300
-232
| -1% | -$23.5K | 0.66% | 78 |
|
|
2014
Q2 | $2.15M | Buy |
22,532
+25
| +0.1% | +$2.24K | 0.6% | 80 |
|
|
2014
Q1 | $2.05M | Buy |
22,507
+584
| +3% | +$56.8K | 0.6% | 81 |
|
|
2013
Q4 | $1.94M | Sell |
21,923
-582
| -3% | -$48.7K | 0.62% | 78 |
|
|
2013
Q3 | $1.86M | Sell |
22,505
-335
| -1% | -$26.3K | 0.63% | 75 |
|
|
2013
Q2 | $1.56M | Buy |
+22,840
| New | +$1.59M | 0.55% | 82 |
|
Other funds holding BBH
MIM
CCA
BFG
Strategic Financial Services's BBH Position: Q1 2026 in Review
Strategic Financial Services sold out of VanEck Biotech ETF (BBH) in Q1 2026, closing a stake of 1,334 shares — an estimated $266K sold.
Strategic Financial Services first reported a position in BBH in Q2 2013 and held it in 32 quarters. The position peaked at $3.65M in Q3 2017. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Strategic Financial Services reported no remaining VanEck Biotech ETF position as of Q1 2026 after selling out during the quarter.
- Strategic Financial Services sold 1,334 VanEck Biotech ETF shares in Q1 2026, an estimated $266K.
- Strategic Financial Services first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 32 quarters.
- Strategic Financial Services's VanEck Biotech ETF position peaked at $3.65M in Q3 2017.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Strategic Financial Services's 13F filing for Q1 2026, filed 8 May 2026.